Robinson James George's Form 4/A amendment
AmendedNymox Pharmaceutical Corp (NYMXF) · filed Jun 26, 2023
- Accession no.
- 0001729637-23-000006
- Filed
- Jun 26, 2023, 10:27 AM ET
- Trade date
- Apr 25-27, 2023
- Filing delay
- 62 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Apr 27, 2023
This filing lists 2 non-derivative transactions. Open-market purchases total $36.8K. It was filed 62 days after the trade.
This amendment replaces 0001729637-23-000003 (filed May 18, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robinson James GeorgeCIK 0001651844 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 25, 2023 | Common Stock | PPurchaseAcquired | +40,000 | $0.45 | +$18,000 | 4,742,065 | Direct | |
| Apr 27, 2023 | Common Stock | PPurchaseAcquired | +40,000 | $0.47 | +$18,800 | 4,782,065 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.